---
figid: PMC6877906__JIR2019-1824624.001
figlink: /pmc/articles/PMC6877906/figure/fig1/
number: F1
caption: 'MyD88-dependent and TRIF-dependent TLR signaling pathways. Ligand binding
  of TLRs by their respective ligands induces dimerization of TLRs and initiates MyD88-dependent
  or TRIF-dependent signaling cascades. The presence of coreceptors, such as CD14
  for TLR2, TLR3, TLR4, TLR7, and TLR9, CD36 for TLR2 and TLR6, and CD44 for TLR4,
  promotes ligand binding efficiency to TLRs. MD2 is a receptor component associated
  with TLR4 and enables TLR4 to respond to LPS. Activation of TLR1-TLR2 by the lipopeptide
  Pam3CSK, TLR2-TLR6 by the lipopeptide Malp2, TLR5 by flagellin, or TLR4 by LPS recruits
  MyD88 through the adaptor molecule TIRAP. MyD88 then recruits and activates the
  IRAK complex, which in turn activates TRAF6, which serves as a platform to recruit
  and activate TAK1 in cooperation with TAB1-3. Once activated, TAK1 activates the
  IKK-NFκB pathway and the MAPK- (including P38, ERK1/2, and JNK) AP1 pathway. Activated
  NFκB or AP1 translocates to the nucleus, driving the transcription of genes encoding
  proinflammatory cytokines, antimicrobial peptides, and costimulatory molecules.
  Activation of endosomal TLR7 by ssRNA or guanosine, TLR8 by ssRNA, or TLR9 by CpG-DNA
  not only initiates the MyD88-TRAF6-dependent activation of AP1 and NFκB but also
  triggers the IRAK-, TRAF6-, TRAF3-, and IKKα-dependent activation of IRF7, translocation
  of which induces the transcription of type1 interferon genes including IFNα and
  IFNβ. In contrast, activation of TLR3 by dsRNA initiates the TRIF-dependent pathway,
  whereas TLR4 activation induces both MyD88- and TRIF-dependent pathways. Once recruited
  to the intracellular domain of TLRs by TRAM, TRIF initiates a TRAF3-dependent activation
  of the TBK1-type 1 IFN pathway and/or a TRAF6-dependent activation of the TAK1-proinflammatory
  cytokine pathway. The TRAF3-dependent activation of TBK1 and IKKε and TBK1-mediated
  activation of AKT result in the coordinate activation of the transcription factor
  IRF3, which translocates to the nucleus and induces the transcription of type 1
  interferon genes upon activation. Pam3CSK4: tripalmitoyl-S-glycero-Cys-(Lys)4; Malp2:
  macrophage-activating lipopeptide-2; LPS: lipopolysaccharide; dsRNA: double-stranded
  RNA; ssRNA: single-stranded RNA; CpG: deoxycytidyl-phosphate-deoxyguanosine; MyD88:
  myeloid differentiation primary response gene 88; TIRAP: TIR domain-containing adaptor
  protein; TRAM: TRIF-related adaptor molecule; TRIF: TIR domain-containing adaptor
  inducing IFNβ; TRAF: TNFR-associated factor; IRAK: IL1R-associated kinase; TAK:
  transforming growth factor beta-activated kinase 1; TAB: TAK1-binding protein; IKK:
  inhibitor of nuclear factor kappa-B kinase; NFκB: nuclear factor kappa-light-chain-enhancer
  of activated B cells; IκB: inhibitor of NFκB; TBK1: TANK binding kinase 1; AMPs:
  antimicrobial peptides.'
pmcid: PMC6877906
papertitle: The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic
  Dermatitis.
reftext: Lixiang Sun, et al. J Immunol Res. 2019;2019:1824624.
pmc_ranked_result_index: '87861'
pathway_score: 0.9568999
filename: JIR2019-1824624.001.jpg
figtitle: MyD88-dependent and TRIF-dependent TLR signaling pathways
year: '2019'
organisms:
- Homo sapiens
ndex: a8449605-dee7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6877906__JIR2019-1824624.001.html
  '@type': Dataset
  description: 'MyD88-dependent and TRIF-dependent TLR signaling pathways. Ligand
    binding of TLRs by their respective ligands induces dimerization of TLRs and initiates
    MyD88-dependent or TRIF-dependent signaling cascades. The presence of coreceptors,
    such as CD14 for TLR2, TLR3, TLR4, TLR7, and TLR9, CD36 for TLR2 and TLR6, and
    CD44 for TLR4, promotes ligand binding efficiency to TLRs. MD2 is a receptor component
    associated with TLR4 and enables TLR4 to respond to LPS. Activation of TLR1-TLR2
    by the lipopeptide Pam3CSK, TLR2-TLR6 by the lipopeptide Malp2, TLR5 by flagellin,
    or TLR4 by LPS recruits MyD88 through the adaptor molecule TIRAP. MyD88 then recruits
    and activates the IRAK complex, which in turn activates TRAF6, which serves as
    a platform to recruit and activate TAK1 in cooperation with TAB1-3. Once activated,
    TAK1 activates the IKK-NFκB pathway and the MAPK- (including P38, ERK1/2, and
    JNK) AP1 pathway. Activated NFκB or AP1 translocates to the nucleus, driving the
    transcription of genes encoding proinflammatory cytokines, antimicrobial peptides,
    and costimulatory molecules. Activation of endosomal TLR7 by ssRNA or guanosine,
    TLR8 by ssRNA, or TLR9 by CpG-DNA not only initiates the MyD88-TRAF6-dependent
    activation of AP1 and NFκB but also triggers the IRAK-, TRAF6-, TRAF3-, and IKKα-dependent
    activation of IRF7, translocation of which induces the transcription of type1
    interferon genes including IFNα and IFNβ. In contrast, activation of TLR3 by dsRNA
    initiates the TRIF-dependent pathway, whereas TLR4 activation induces both MyD88-
    and TRIF-dependent pathways. Once recruited to the intracellular domain of TLRs
    by TRAM, TRIF initiates a TRAF3-dependent activation of the TBK1-type 1 IFN pathway
    and/or a TRAF6-dependent activation of the TAK1-proinflammatory cytokine pathway.
    The TRAF3-dependent activation of TBK1 and IKKε and TBK1-mediated activation of
    AKT result in the coordinate activation of the transcription factor IRF3, which
    translocates to the nucleus and induces the transcription of type 1 interferon
    genes upon activation. Pam3CSK4: tripalmitoyl-S-glycero-Cys-(Lys)4; Malp2: macrophage-activating
    lipopeptide-2; LPS: lipopolysaccharide; dsRNA: double-stranded RNA; ssRNA: single-stranded
    RNA; CpG: deoxycytidyl-phosphate-deoxyguanosine; MyD88: myeloid differentiation
    primary response gene 88; TIRAP: TIR domain-containing adaptor protein; TRAM:
    TRIF-related adaptor molecule; TRIF: TIR domain-containing adaptor inducing IFNβ;
    TRAF: TNFR-associated factor; IRAK: IL1R-associated kinase; TAK: transforming
    growth factor beta-activated kinase 1; TAB: TAK1-binding protein; IKK: inhibitor
    of nuclear factor kappa-B kinase; NFκB: nuclear factor kappa-light-chain-enhancer
    of activated B cells; IκB: inhibitor of NFκB; TBK1: TANK binding kinase 1; AMPs:
    antimicrobial peptides.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT1
  - AKT2
  - FOS
  - FOSB
  - FOSL2
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - BTK
  - CD14
  - CD36
  - MAPK3
  - MAPK1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - IFNW1
  - IFNK
  - IRAK1
  - IRAK2
  - IRAK4
  - IRAK3
  - IRF3
  - IRF7
  - MAPK8
  - MAPK9
  - MAPK10
  - IRF6
  - LY96
  - MYD88
  - NFKB1
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK14
  - TAB2
  - TAB3
  - TAB1
  - TBK1
  - TIRAP
  - TLR6
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR7
  - TLR8
  - TLR9
  - TRAF3
  - TRAF6
  - O00
  - LPS
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: CD14
  symbol: CD14
  source: hgnc_symbol
  hgnc_symbol: CD14
  entrez: '929'
- word: CD36
  symbol: CD36
  source: hgnc_symbol
  hgnc_symbol: CD36
  entrez: '948'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: Ikka
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNW1
  entrez: '3467'
- word: Interferons
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNK
  entrez: '56832'
- word: IRAK1/2/4/M
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: IRAK1/2/4/M
  symbol: IRAK2
  source: hgnc_symbol
  hgnc_symbol: IRAK2
  entrez: '3656'
- word: IRAK1/2/4/M
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: IRAK1/2/4/M
  symbol: IRAK-M
  source: hgnc_alias_symbol
  hgnc_symbol: IRAK3
  entrez: '11213'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: MD2
  symbol: MD-2
  source: hgnc_alias_symbol
  hgnc_symbol: LY96
  entrez: '23643'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: TAB1/2/3
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: TAB1/2/3
  symbol: TAB3
  source: hgnc_symbol
  hgnc_symbol: TAB3
  entrez: '257397'
- word: TAB1/2/3
  symbol: TAB1
  source: hgnc_symbol
  hgnc_symbol: TAB1
  entrez: '10454'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: TIRAP
  symbol: TIRAP
  source: hgnc_symbol
  hgnc_symbol: TIRAP
  entrez: '114609'
- word: TLR2/6
  symbol: TLR6
  source: hgnc_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR2/6
  symbol: TLR2
  source: hgnc_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR5
  symbol: TLR5
  source: hgnc_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR7
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR8
  symbol: TLR8
  source: hgnc_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR9
  symbol: TLR9
  source: hgnc_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
chemicals:
- word: O00
  source: MESH
  identifier: D014800
diseases:
- word: LPS
  source: MESH
  identifier: C536528
figid_alias: PMC6877906__F1
redirect_from: /figures/PMC6877906__F1
figtype: Figure
---
